Trial intelligence / Profile preview

Tapentadol for prevention of chronic postoperative pain after inguinal hernia or knee surgery

2018-004804-21Phase 4Active

Sponsor
Leiden University Medical Center
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Persistent postsurgical pain (PPSP) comparing Tapentadol with Placebo (2 arms). Primary endpoint: Effect of tapentadol versus placebo on development of chronic pain. Started Jan 2020; status: active.

02

Drugs

tapentadol
03

Conditions

Persistent postsurgical pain (PPSP)

Beyond the preview

Go deeper on 2018-004804-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-004804-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call